Article: Dade Behring Receives FDA Clearance for PFA-100(R) Platelet-Function Analyzer

New technology provides fast, accurate, cost-effective detection

 
of platelet-function disorders potentially affecting millions. 

DEERFIELD, Ill., Nov. 24 /PRNewswire/ -- Dade Behring Inc. announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing the PFA-100(R) platelet-function analyzer to clinical laboratories in the United States. The system provides new technology permitting fast, accurate and cost-effective detection of platelet dysfunction for millions of patients with a range of acquired or inherited conditions.

Platelets are a cellular element of the blood that ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!